FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200327320> ?p ?o ?g. }

• W4200327320 abstract "To date, only corticosteroids and interleukin-6 (IL-6) inhibitors have been shown to reduce mortality of hospitalized patients with COVID-19. In this literature review, we aimed to summarize infection risk of IL inhibitors, with or without the use of corticosteroids, used to treat hospitalized patients with COVID-19.A literature search was conducted using the following evidence-based medicine reviews: Cochrane Central Register of Controlled Trials; Cochrane Database of Systematic Reviews; Embase; Ovid Medline; and Epub Ahead of Print, In-Process, In-Data-Review & Other Non-Indexed Citations, Daily and Versions 1946 to April 28, 2021. All relevant articles were identified using the search terms COVID-19 or SARS-coronavirus-2, infections, interleukins, inpatients, adults, and incidence.We identified 36 studies of which 2 were meta-analyses, 5 were randomized controlled trials, 9 were prospective studies, and 20 were retrospective studies. When anakinra was compared with control, 2 studies reported an increased risk of infection, and 3 studies reported a similar or decreased incidence of infection. Canakinumab had a lower associated incidence of infection compared with placebo in one study. When sarilumab was compared with placebo, one study reported an increased risk of infection. Nine studies comparing tocilizumab with placebo reported decreased or no difference in infection risk (odds ratio [OR] for the studies ranged from 0.39-1.21). Fourteen studies comparing tocilizumab with placebo reported an increased risk of infection, ranging from 9.1% to 63.0% (OR for the studies ranged from 1.85-5.04). Infection most commonly presented as bacteremia. Of the 6 studies comparing tocilizumab and corticosteroid use with placebo, 4 reported a nonsignificant increase toward corticosteroids being associated with bacterial infections (OR ranged from 2.76-3.8), and 2 studies reported no increased association with a higher infection risk.Our literature review showed mixed results with variable significance for the association of IL-6 inhibitors with risk of infections in patients with COVID-19." @default.
• W4200327320 created "2021-12-31" @default.
• W4200327320 creator A5008381191 @default.
• W4200327320 creator A5014593593 @default.
• W4200327320 creator A5015092214 @default.
• W4200327320 creator A5019246166 @default.
• W4200327320 creator A5022201674 @default.
• W4200327320 creator A5036529101 @default.
• W4200327320 creator A5037385395 @default.
• W4200327320 creator A5050123798 @default.
• W4200327320 creator A5051325054 @default.
• W4200327320 creator A5052996857 @default.
• W4200327320 creator A5058397626 @default.
• W4200327320 creator A5068466173 @default.
• W4200327320 creator A5071610398 @default.
• W4200327320 creator A5072824454 @default.
• W4200327320 creator A5079119849 @default.
• W4200327320 creator A5079725698 @default.
• W4200327320 creator A5081951764 @default.
• W4200327320 creator A5088511706 @default.
• W4200327320 date "2021-12-10" @default.
• W4200327320 modified "2023-09-29" @default.
• W4200327320 title "Infection risk with the use of interleukin inhibitors in hospitalized patients with COVID-19: A narrative review" @default.
• W4200327320 cites W1975501001 @default.
• W4200327320 cites W2112605252 @default.
• W4200327320 cites W2114308202 @default.
• W4200327320 cites W2159197023 @default.
• W4200327320 cites W2171783221 @default.
• W4200327320 cites W3009031425 @default.
• W4200327320 cites W3015536776 @default.
• W4200327320 cites W3021577619 @default.
• W4200327320 cites W3023088605 @default.
• W4200327320 cites W3026277345 @default.
• W4200327320 cites W3026301261 @default.
• W4200327320 cites W3030871984 @default.
• W4200327320 cites W3033071371 @default.
• W4200327320 cites W3036398841 @default.
• W4200327320 cites W3036430736 @default.
• W4200327320 cites W3038241707 @default.
• W4200327320 cites W3041464116 @default.
• W4200327320 cites W3042042989 @default.
• W4200327320 cites W3044965497 @default.
• W4200327320 cites W3045667662 @default.
• W4200327320 cites W3046740571 @default.
• W4200327320 cites W3048601848 @default.
• W4200327320 cites W3048767564 @default.
• W4200327320 cites W3080283740 @default.
• W4200327320 cites W3093604087 @default.
• W4200327320 cites W3093837118 @default.
• W4200327320 cites W3094209984 @default.
• W4200327320 cites W3094609299 @default.
• W4200327320 cites W3097807388 @default.
• W4200327320 cites W3099578333 @default.
• W4200327320 cites W3101560841 @default.
• W4200327320 cites W3104852096 @default.
• W4200327320 cites W3107887572 @default.
• W4200327320 cites W3110735907 @default.
• W4200327320 cites W3110844195 @default.
• W4200327320 cites W3110977870 @default.
• W4200327320 cites W3112686683 @default.
• W4200327320 cites W3122058843 @default.
• W4200327320 cites W3123360693 @default.
• W4200327320 cites W3127425621 @default.
• W4200327320 cites W3128695597 @default.
• W4200327320 cites W3129869280 @default.
• W4200327320 cites W3130126061 @default.
• W4200327320 cites W3133478102 @default.
• W4200327320 cites W3143028588 @default.
• W4200327320 cites W3144038434 @default.
• W4200327320 cites W3181530483 @default.
• W4200327320 cites W3183356099 @default.
• W4200327320 cites W3198379317 @default.
• W4200327320 cites W33894617 @default.
• W4200327320 cites W4206449744 @default.
• W4200327320 doi "https://doi.org/10.53854/liim-2904-1" @default.
• W4200327320 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35146357" @default.
• W4200327320 hasPublicationYear "2021" @default.
• W4200327320 type Work @default.
• W4200327320 citedByCount "10" @default.
• W4200327320 countsByYear W42003273202021 @default.
• W4200327320 countsByYear W42003273202022 @default.
• W4200327320 countsByYear W42003273202023 @default.
• W4200327320 crossrefType "journal-article" @default.
• W4200327320 hasAuthorship W4200327320A5008381191 @default.
• W4200327320 hasAuthorship W4200327320A5014593593 @default.
• W4200327320 hasAuthorship W4200327320A5015092214 @default.
• W4200327320 hasAuthorship W4200327320A5019246166 @default.
• W4200327320 hasAuthorship W4200327320A5022201674 @default.
• W4200327320 hasAuthorship W4200327320A5036529101 @default.
• W4200327320 hasAuthorship W4200327320A5037385395 @default.
• W4200327320 hasAuthorship W4200327320A5050123798 @default.
• W4200327320 hasAuthorship W4200327320A5051325054 @default.
• W4200327320 hasAuthorship W4200327320A5052996857 @default.
• W4200327320 hasAuthorship W4200327320A5058397626 @default.
• W4200327320 hasAuthorship W4200327320A5068466173 @default.
• W4200327320 hasAuthorship W4200327320A5071610398 @default.
• W4200327320 hasAuthorship W4200327320A5072824454 @default.
• W4200327320 hasAuthorship W4200327320A5079119849 @default.
• W4200327320 hasAuthorship W4200327320A5079725698 @default.
• W4200327320 hasAuthorship W4200327320A5081951764 @default.

• next